JP Morgan Maintains Overweight on Zoetis, Lowers Price Target to $225

Benzinga · 10/17/2022 12:49
JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $250 to $225.